CDX2 expression in primary skin tumors—case series and review of the literature - ScienceDirect
Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas - Modern Pathology
Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma | Modern Pathology
CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer - ScienceDirect
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
CDX2 - an overview | ScienceDirect Topics
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts | British Journal of Cancer
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis | Laboratory Investigation
Current Oncology | Free Full-Text | Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour—State of the Art and Perspectives
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
Diagnostics | Free Full-Text | CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses
Distribution of CDX2 expression in patients with colorectal cancer and... | Download Scientific Diagram
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - ScienceDirect
CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression | Cell Death & Disease
Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer - Weimin Xu, Yilian Zhu, Wei Shen, Wenjun Ding, Tingyu Wu, Yuegui Guo, Xiaobing Chen, Mingxia Zhou, Yingwei Chen,
JCI Insight - LIN28B induces a differentiation program through CDX2 in colon cancer
CDX2 Antibody - Biocare Medical
CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research
CDX1 and CDX2 immunohistochemistry and image analysis at different... | Download Scientific Diagram
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer - Modern Pathology
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
